Tag Archive | "Drug"

Findings point to an 'off switch' for drug resistance in cancer

Findings point to an 'off switch' for drug resistance in cancer Now, scientists at the Salk Institute have uncovered details about how cancer is able to become drug resistant over time, a phenomenon that occurs because cancer cells within the same tumor aren't identical—the cells have slight genetic variation, or … Full News here – […]

Read the full story

Posted in CancerComments (0)

Pulmonary Arterial Hypertension: A Better Understanding of the Three New Drug

Pulmonary Arterial Hypertension: A Better Understanding of the Three New Drug … It doesn't seem to have a dominant role in group 1 disease, but it can be used instead of tadalafil (Adcirca®) or sildenafil (Revatio®). Even though riociguat was studied and approved as a monotherapy, in reality, out in the clinical trenches, it will […]

Read the full story

Posted in SildenafilComments (0)

Erectile Dysfunction Drug Could Affect Vision Of One In 50

Erectile Dysfunction Drug Could Affect Vision Of One In 50 AsianScientist (Oct. 8, 2014) – Sildenafil, the active ingredient in the erectile dysfunction drug Viagra®, could cause unusual visual responses in people who carry a common mutation for eye disease and may have long-term detrimental effects on their … Full News here – Read more […]

Read the full story

Posted in Erectile DysfunctionComments (0)

Confessions of a 'Functional' Drug Addict, Part I: The Illusion Of Self-Worth

Confessions of a 'Functional' Drug Addict, Part I: The Illusion Of Self-Worth Since getting clean and facing the mother of all comedowns, I've started on 20mg of Lexapro a day. My chemically ravaged brain feels more reliable. I feel evened out and largely unperturbed by innate feelings of complete hopelessness, dread and regret. Full News […]

Read the full story

Posted in LexaproComments (0)

'Financial Toxicity:' Who's Really to Blame for High Cancer Drug Prices?

'Financial Toxicity:' Who's Really to Blame for High Cancer Drug Prices? The issue of expensive cancer drugs is hardly new, of course, but 60 Minutes aired a segment that the other night that likely helped highlight the controversy for the mass audience that watches the popular news program. The episode, however, is … Full News […]

Read the full story

Posted in CancerComments (0)

Hyperion, Clal Biotech resolve dispute over diabetes drug

Hyperion, Clal Biotech resolve dispute over diabetes drug Hyperion had bought Israel's Andromeda Biotech – which is developing DiaPep277, a treatment for Type I diabetes that is undergoing a second advanced clinical study – from Clal for $ 12.5 million in June. The deal included milestone payments reaching … Full News here – Read more […]

Read the full story

Posted in DiabetesComments (0)

FDA awards grants to stimulate drug, device development for rare diseases

FDA awards grants to stimulate drug, device development for rare diseases Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations— approximately $ 1.6 million over four years; Dung Le, The Johns Hopkins University (Baltimore, Md.), Phase 2 Study of Folfirinox followed by Ipilimumab/GVAX for the Treatment of … Full News here – Read more […]

Read the full story

Posted in SildenafilComments (0)

Breast Cancer Drug Perjeta Shows Incredible Promise in Clinical Trials

Breast Cancer Drug Perjeta Shows Incredible Promise in Clinical Trials A drug used in the treatment of breast cancer patients has surprising and unprecedented success fighting the disease in a clinical study. Patients treated with the drug Perjeta, manufactured by the Swiss drug maker Roche, saw an increased median … Full News here – Read […]

Read the full story

Posted in DiabetesComments (0)

Faster-acting erectile dysfunction drug gets FDA approval

Faster-acting erectile dysfunction drug gets FDA approval An erectile dysfunction drug that reduces by half the time patients need to take the pill before sexual activity has won approval for marketing in the United States. The drug, Stendra, is the first erectile dysfunction drug approved by the U.S. Food … Full News here – Read […]

Read the full story

Posted in Erectile DysfunctionComments (0)

One million women denied 7p breast cancer drug that can halve chance of

One million women denied 7p breast cancer drug that can halve chance of … Tamoxifen, Raloxifene and Anastrozole block oestrogen and are used to treat breast cancer. But the Medicines and Healthcare Products Regulatory Agency has not licensed them for preventative use, which costs 7p to 61p a day and cuts risk by 40 to […]

Read the full story

Posted in CancerComments (0)

Weekly Injectable Type 2 Diabetes Drug Approved

Weekly Injectable Type 2 Diabetes Drug Approved FRIDAY, Sept. 19, 2014 (HealthDay News) — The U.S. Food and Drug Administration approved a new type 2 diabetes drug, Trulicity, on Thursday. Trulicity is part of a class of once-a-week injectable drugs that help manage blood sugar levels in adults … Full News here – Read more […]

Read the full story

Posted in DiabetesComments (0)

Apricus CEO to Discuss Company's Drug Portfolio, Including Its Topical Cream

Apricus CEO to Discuss Company's Drug Portfolio, Including Its Topical Cream … Mr. Pascoe will discuss the Company's prescription erectile dysfunction treatment Vitaros(R), which was launched commercially in the UK, Germany and Sweden this year and is expected to roll out in other European countries later this year and in 2015. Full News here – […]

Read the full story

Posted in Erectile DysfunctionComments (0)

Chinese Drug Company Wins Approval to Make Generic Version of Viagra

Chinese Drug Company Wins Approval to Make Generic Version of Viagra According to a Citigroup study cited by CNBC, the current Chinese erectile dysfunction drug market is worth 1.7 billion renminbi a year. This could reach as much as 5 billion renminbi, or $ 810 million, by 2018, it said, and generic versions of Viagra […]

Read the full story

Posted in Erectile DysfunctionComments (0)

UPDATE 2-Hyperion to stop diabetes drug development after trial manipulation

UPDATE 2-Hyperion to stop diabetes drug development after trial manipulation The trial is testing the drug, DiaPep277, to treat newly diagnosed Type 1 diabetes patients. DiaPep277 is Andromeda's lead product. "DiaPep was designed to modulate the immunological attack on pancreatic beta cells, a mechanism that several companies … Full News here – Read more on Reuters

Read the full story

Posted in DiabetesComments (0)

Kentucky to Tackle Equine Drug Compounder Concerns

Kentucky to Tackle Equine Drug Compounder Concerns This year Quarter Horse trainer John Stinebaugh received a 16-year suspension and $ 40,000 fine when he had horses test positive for sildenafil, the active ingredient in Viagra. Stinebaugh's attorney told the Albuquerque Journal that the positives … Full News here – Read more on TheHorse.com

Read the full story

Posted in SildenafilComments (0)